1 / 1

Supplementary Figure 3

Ctl sip300. p300. E2F1. Actin. Cisp (24h). Supplementary Figure 3. A. B. 25. NT. Cisp (24h). 20. Apoptosis (%). 15. 10. 5. 0. Ctl. sip300. Neutralization of p300 prevents E2F1 accumulation and apoptosis in response to cisplatin.

samara
Download Presentation

Supplementary Figure 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ctl sip300 p300 E2F1 Actin Cisp (24h) Supplementary Figure 3 A B 25 NT Cisp (24h) 20 Apoptosis (%) 15 10 5 0 Ctl sip300 Neutralization of p300 prevents E2F1 accumulation and apoptosis in response to cisplatin. H358 cells were transfected for 48 hours with either control (Ctl) or p300 siRNA and exposed to 50M cisplatin for an additional 24 hours. (A) Western blotting was performed using anti-E2F1 or anti-p300 antibody. Actin was used as a loading control. (B) Apoptosis was studied by Active Caspase 3 staining followed by FACS analysis.

More Related